AriBio Co., Ltd. receives Notice of Acceptance for POLARIS-AD, a Phase 3 early Alzheimer’s disease clinical trial from the Medicines and Healthcare Products Regulatory Agency in the United Kingdom.
Cynata Therapeutics Limited, a clinical-stage biotechnology company specialising in cell therapeutics, has completed initial analysis of wound surface area in the first 16 patients in its Phase 1 clinical trial of CYP-006TK in diabetic foot ulcers, up to the 10-week follow-up time point.
Encouraging Initial Data from CYP-006TK Diabetic Foot Ulcer Clinical Trial Read More »
Armonica Technologies, Inc., a pioneer in sample-prep free direct optical DNA sequencing, announced the appointment of biotech veteran Emily Milsovic to the Board of Directors.
Armonica Technologies announces Emily Milsovic joins Board of Directors Read More »
The inspiration behind two blockbuster biopharma deals in 2023, anti-TLIA drugs have the potential to improve efficacy and durability of response for a number of autoimmune diseases, experts tell BioSpace.
TL1A Inhibitors Could Usher in New Era for IBD Treatment Read More »
Patient advocacy groups aided in the development of the very first marketed drugs for certain rare diseases, including progeria and Friedreich’s ataxia.
Turning to Patients to Help Drive Rare Disease Drug Development Read More »
The cancer space has been aflutter with notable approvals so far this year, but there are several more candidates with significant data expected over the next four months. BioSpace takes a closer look.
6 First-Half 2024 Oncology Data Readouts to Watch Read More »
Representing Denali Therapeutics, I recently participated in a workshop that brought together FDA representatives, patient advocates, academic physicians and scientists and industry to discuss strategies to speed therapies for patients with rare degenerative illnesses.
Accelerating a Path to New Treatments for Rare Neuronopathic MPS Diseases Read More »
No es mucho lo que se sabe acerca de los escurridizos animales submarinos conocidos popularmente como “arañas de mar”. Bastante parecidas a las arañas de patas largas, estos animales, que no son arañas verdaderas, no suelen ser más grandes que una uña d …
En un nuevo estudio, se ha examinado esta cuestión para el caso concreto de los clientes que desean realizar trámites sobre pólizas de seguros. Los chatbots o robots conversacionales son programas informáticos sofisticados (a veces inteligencias artificiales) que poseen l …
¿Inspiran confianza los chatbots a la hora de realizar trámites? Read More »
La Esclerosis Lateral Amiotrófica (ELA) provoca la pérdida de neuronas motoras y la parálisis de los músculos esqueléticos y, hasta ahora, no existe ninguna cura ni tratamiento efectivos. Un estudio liderado por el Centro de Biomateriales e Ingenierí …
Posible estrategia para frenar la degeneración neuromuscular en pacientes con ELA Read More »
